Dow Up 0.11% Nasdaq Up 0.50%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
71.22 Up 1.60(2.30%) Aug 29, 4:00PM EDT
|After Hours : 71.23 Up 0.01 (0.01%) Aug 29, 4:44PM EDT
Prev Close:69.62
Open:69.75
Bid:66.10 x 300
Ask:71.98 x 300
1y Target Est:83.13
Beta:0.64
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:69.68 - 71.73
52wk Range:55.04 - 84.25
Volume:678,442
Avg Vol (3m):1,135,360
Market Cap:10.48B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 2.30%10.48B
FOLDDown 1.10%565.86M
SHPGDown 0.21%47.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.28
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback